Insider · CIK 0001920509

Santos da Silva Jorge

Reports to the SEC for 1 company · ZUG

sec.gov

Transactions

Companies

Filings

CIK

0001920509

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-10	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−68.3K sh	$20.02	−$1.37M	2,774,893
2026-07-09	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−33.9K sh	$20.01	−$679K	2,843,182
2026-07-01	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−47.8K sh	$20.03	−$957K	2,877,118
2026-04-13	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−51.9K sh	$18.23	−$946K	2,924,893
2026-04-10	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−98.1K sh	$18.41	−$1.81M	2,976,766
2026-01-07	MLTXMoonLake Immunotherapeutics · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+520K sh	—	—	520,342
2025-12-19	MLTXMoonLake ImmunotherapeuticsC Conversion	Director, Chief Executive Officer	CConversion	+196K sh	—	—	3,074,893
2025-12-19	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−196K sh	—	—	0
2025-12-19	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Director, Chief Executive Officer	CConversion	−5,836 sh	—	—	0
2025-12-09	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−70K sh	$14.49	−$1.01M	2,878,577
2025-12-08	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−130K sh	$15.08	−$1.96M	2,948,577
2025-02-27	MLTXMoonLake ImmunotherapeuticsA Award	Director, Chief Executive Officer	AAward	+95.8K sh	—	—	3,078,577
2024-02-29	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−4,740 sh	$55.89	−$265K	2,982,814
2024-02-28	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−56.1K sh	$55.00	−$3.08M	2,987,554
2024-02-27	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−62.8K sh	$55.00	−$3.45M	3,043,619
2024-02-21	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−1,125 sh	$55.27	−$62.2K	3,106,429
2024-02-20	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−20K sh	$57.44	−$1.15M	3,107,554
2024-02-16	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−20K sh	$60.15	−$1.2M	3,127,554
2024-02-15	MLTXMoonLake ImmunotherapeuticsS Sale	Director, Chief Executive Officer	SSale	−20K sh	$60.18	−$1.2M	3,147,554
2023-10-01	MLTXMoonLake ImmunotherapeuticsC Conversion	Director, Chief Executive Officer	CConversion	+3.03M sh	—	—	3,027,483
2023-10-01	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−3.03M sh	—	—	0
2023-10-01	MLTXMoonLake ImmunotherapeuticsC Conversion	Director, Chief Executive Officer	CConversion	+140K sh	—	—	3,167,554
2023-10-01	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−140K sh	—	—	217,374
2023-10-01	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Director, Chief Executive Officer	CConversion	−90K sh	—	—	0
2023-10-01	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Director, Chief Executive Officer	CConversion	−4,164 sh	—	—	5,836

Recent filings

Accepted (ET)
Jul 134
Santos da Silva Jorge0001213900-26-077564
SEC(opens sec.gov)
Jul 24
Santos da Silva Jorge0001213900-26-074964
SEC(opens sec.gov)
Apr 144
Santos da Silva Jorge0001213900-26-043647
SEC(opens sec.gov)
Jan 94
Santos da Silva Jorge0001213900-26-002906
SEC(opens sec.gov)
Dec 224
Santos da Silva Jorge0001213900-25-124510
SEC(opens sec.gov)
Dec 104
Santos da Silva Jorge0001213900-25-120106
SEC(opens sec.gov)
Mar 34
Santos da Silva Jorge0001213900-25-019674
SEC(opens sec.gov)
Feb 294
Santos da Silva Jorge0001213900-24-018675
SEC(opens sec.gov)
Feb 234
Santos da Silva Jorge0001213900-24-016544
SEC(opens sec.gov)
Feb 204
Santos da Silva Jorge0001213900-24-015446
SEC(opens sec.gov)
Oct 34
Santos da Silva Jorge0001013762-23-001297
SEC(opens sec.gov)

Companies

MoonLake ImmunotherapeuticsDirector, Chief Executive OfficerMLTX

Address

C/O MOONLAKE IMMUNOTHERAPEUTICS DORFSTRASSE 29

ZUG, 6300